OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Model
Economics
111 Publications
found
Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness.
b
Children (Basel, Switzerland)
May 12, 2021
p
Newborn Screening
c
Economics
Model
Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.
b
The lancet. HIV
April 1, 2021
p
HIV POCT
c
Economics
Model
Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study.
b
The Lancet. Public health
March 1, 2021
p
COVID-19
c
Clinical outcomes
Economics
Highlighted
Model
Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
b
AIDS (London, England)
February 2, 2021
p
HIV POCT
c
Economics
Model
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.
b
The Lancet. Global health
February 1, 2021
p
COVID-19
c
Economics
Model
Economic evaluation of alternative testing regimes and settings to detect undiagnosed HIV in Australia.
b
BMC health services research
January 7, 2021
p
HIV POCT
c
Economics
Model
The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts.
b
Frontiers in pediatrics
January 1, 2021
p
Newborn Screening
c
Economics
Model
The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia.
b
PloS one
January 1, 2021
p
HIV POCT
c
Economics
Model
EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong – A cost-effectiveness analysis.
b
PloS one
January 1, 2021
p
Cancer
c
Economics
Model
Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.
b
The Journal of pediatrics
December 1, 2020
p
Newborn Screening
c
Economics
Model
Previous Page
1
…
3
4
5
6
7
…
12
Next Page
